Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.84 USD | -1.07% | +2.14% | -43.43% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.43% | 385M | |
+8.73% | 114B | |
+10.88% | 104B | |
-12.79% | 22.41B | |
-1.11% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.97% | 17.89B | |
+7.88% | 14.28B | |
+36.43% | 12.55B |
- Stock Market
- Equities
- TRML Stock
- News Tourmaline Bio, Inc.
- Morgan Stanley Adjusts Talaris Therapeutics Price Target to $21 From $20, Maintains Overweight Rating